The definitive diagnosis is confirmed by excluding other malignancies with a panel of immunohistochemical markers that include keratins, S100 protein, SOX10; smooth muscle actin (SMA); and desmin, expressed in metastatic sarcomatoid carcinoma, melanoma, and pleomorphic myogenic sarcomas, respectively. This evidence concerns the gene SOX10 and melanoma.